Sara Giovani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Giovani has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adelaide Ballerini
Cardiogenetics Laboratory, Pediatric and Transitional Cardiology Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
2 shared publications - Alberto Marchi
Pediatric and Transitional Cardiology Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
2 shared publications - Alessia Gozzini
Cardiogenetics Laboratory, Pediatric and Transitional Cardiology Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
2 shared publications - Alessia Tomberli
Pediatric and Transitional Cardiology Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
2 shared publications - Davide Mei
Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy
2 shared publications - Elena Bennati
Cardiology, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
2 shared publications
Latest Publications
- Open Access
- 12 September 2025
- Published by MDPI AG in Cardiogenetics
- Vol. 15 (3) , 25
Genetic Profile of Pediatric-Onset Cardiac Channelopathies
This study investigates the genetic background of pediatric-onset cardiac channelopathies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death, whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 was detected in an LQTS patient, and a pathogenic CALM1 variant was identified in a child. A compound heterozygous KCNQ1 was consistent with Jervell and Lange-Nielsen syndrome. In light of these data, genetic testing is crucial for diagnosis, prognosis, and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.
- 12 September 2025
- Published by MDPI AG in Cardiogenetics
- Vol. 15 (3) , 25
Open AccessGenetic Profile of Pediatric-Onset Cardiac Channelopathies
This study investigates the genetic background of pediatric-onset cardiac channelopathies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death, whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 was detected in an LQTS patient, and a pathogenic CALM1 variant was identified in a child. A compound heterozygous KCNQ1 was consistent with Jervell and Lange-Nielsen syndrome. In light of these data, genetic testing is crucial for diagnosis, prognosis, and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.
- Open Access
- 22 July 2025
- Published by MDPI AG in Preprints.org
Genetic Profile of Pediatric-Onset Cardiac Channelopathies
This study investigates the genetic background of pediatric-onset cardiac channelopa-thies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (< 18 years of age) diagnosed with different channelopathies (LQTS, BrS, CPVT, SQTS, and conduction disorders), along with 40 of their family members, using Next Generation Sequencing (NGS) after genetic counselling. A causative genetic variant was found in 47% of cases, mainly in KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 has been detected in an LQTS patient, and a pathogenic CALM1 variant has been identified in a child. A compound heterozygous KCNQ1 was consistent with the Jervell and Lange-Nielsen syndrome. In the light of these data genetic testing is crucial for diagnosis, prognosis and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.
- 22 July 2025
- Published by MDPI AG in Preprints.org
Open AccessGenetic Profile of Pediatric-Onset Cardiac Channelopathies
This study investigates the genetic background of pediatric-onset cardiac channelopa-thies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (< 18 years of age) diagnosed with different channelopathies (LQTS, BrS, CPVT, SQTS, and conduction disorders), along with 40 of their family members, using Next Generation Sequencing (NGS) after genetic counselling. A causative genetic variant was found in 47% of cases, mainly in KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 has been detected in an LQTS patient, and a pathogenic CALM1 variant has been identified in a child. A compound heterozygous KCNQ1 was consistent with the Jervell and Lange-Nielsen syndrome. In the light of these data genetic testing is crucial for diagnosis, prognosis and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.